What is the current Price Target for the Cingulate stock?

The average Cingulate target price is $20.40. This is 436.84% higher than the current stock price. The highest price target is 1,613.16%, the lowest is 112.63%. 7 Analysts have issued a price target Cingulate 2026 .

How high will the Cingulate stock rise?

No reliable answer can be given as to how high the Cingulate stock will rise. The performance of stocks, including the Cingulate stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cingulate stock today?

The performance of Cingulate stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cingulate stock fall?

The decline in Cingulate stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cingulate Forecast, price target & analysts

$3.69

2.86% today

Nasdaq, Nov 04, 03:52 pm CET

ISIN

US17248W3034

Symbol

CING

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Cingulate Target price 2025 - Analyst rating & recommendation

Cingulate Classifications & Recommendation:

Buy

89%

Hold

11%

Cingulate Price Target

Target Price	$20.40
Price	$3.80
Potential	436.84% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Cingulate 2026 . The average Cingulate target price is $20.40. This is 436.84% register free of charge higher than the current stock price. The highest price target is $65.10 1,613.16% register free of charge , the lowest is $8.08 112.63% register free of charge .
	A rating was issued by 9 analysts: 8 Analysts recommend Cingulate to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cingulate stock has an average upside potential 2026 of 436.84% register free of charge . Most analysts recommend the Cingulate stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-10.20	-3.62
	96.73%	64.51%
P/E		negative

7 Analysts have issued a Cingulate forecast for earnings per share. The average Cingulate EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-10.20	96.73%
2025	$-3.62 64.51% Unlock
2026	$-2.38 34.25% Unlock
2027	$-0.57 76.05% Unlock

Current	-0.93	123.23%
2025	-1.05 13.01% Unlock
2026	-1.59 51.43% Unlock
2027	-6.65 318.24% Unlock

Cingulate...

Current Cingulate Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Roth Capital	Locked ➜ Locked	Locked	Oct 15 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Aug 22 2025
Ascendiant Capital	Locked ➜ Locked	Locked	May 27 2025
Roth Capital	Locked ➜ Locked	Locked	May 19 2025
Ascendiant Capital	Locked ➜ Locked	Locked	Apr 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 06 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 30 2025

Analyst Rating	Date
Locked Roth Capital: Locked ➜ Locked	Oct 15 2025
Locked Ascendiant Capital: Locked ➜ Locked	Aug 22 2025
Locked Ascendiant Capital: Locked ➜ Locked	May 27 2025
Locked Roth Capital: Locked ➜ Locked	May 19 2025
Locked Ascendiant Capital: Locked ➜ Locked	Apr 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 06 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 30 2025

Discover more stocks with a high price target

TUI 51.62%

Adidas 49.71%

Deutsche Telekom 45.44%

Novo Nordisk 42.34%

BYD 40.09%

Meta Platforms (Facebook) 39.23%

BioNTech SE - ADR 34.42%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now